Rational optimization of a human neutralizing antibody of SARS-CoV-2

SARS-CoV-2 has caused a worldwide epidemic of coronavirus disease 19 (COVID-19). Antibody drugs present an effective weapon for tens of millions of COVID-19 patients. Antibodies disrupting the interactions between the receptor-binding domain (RBD) of SARS-CoV-2 S protein and the angiotensin converti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiao, Wu, Fei, Lin, Dan, Kong, Weikang, Cai, Xueting, Yang, Jie, Sun, Xiaoyan, Cao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196228/
https://www.ncbi.nlm.nih.gov/pubmed/34147856
http://dx.doi.org/10.1016/j.compbiomed.2021.104550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196228/
https://www.ncbi.nlm.nih.gov/pubmed/34147856
http://dx.doi.org/10.1016/j.compbiomed.2021.104550

Ejemplares similares